-
Most Popular
Search Results
176 results for yuii
Why Is Nektar Therapeutics (NKTR) Stock Down 39% Today?
Nektar Therapeutics (NKTR) stock is taking a beating on Friday following the release of poor Phase 2 clinical trial data.
Why Is BiomX (PHGE) Stock Down 11% Today?
BiomX (PHGE) stock is taking a beating on Wednesday after the clinical-stage microbiome company revealed details of a new private placement.
Why Is Redhill Biopharma (RDHL) Stock Up 32% Today?
Redhill Biopharma (RDHL) stock is rocketing higher on Friday after getting positive patent news from the USPTO for RHB-204.
Why Is Fate Therapeutics (FATE) Stock Down 62% Today?
Fate Therapeutics (FATE) stock is falling on Friday after the company announced the termination of its collaboration with Janssen Biotech.
Why Is Leafly (LFLY) Stock Getting High Today?
Leafly (LFLY) stock is in the news Monday after reaching an agreement with Uber’s (UBER) Uber Eats for the delivery of cannabis products.
Why Is Hoth Therapeutics (HOTH) Stock Up 24% Today?
Hoth Therapeutics (HOTH) stock is rising higher on Monday with heavy trading and positive results from a Phase 1 clinical trial of BioLexa.
Why Is NexImmune (NEXI) Stock Down 4% Today?
NexImmune (NEXI) stock is falling on Friday as the immunotherapies company’s shares come off of a recent high earlier this week.
Why Is Xortx Therapeutics (XRTX) Stock Moving Today?
Xortx Therapeutics (XRTX) stock is on the move Monday after the company reported positive results from a clinical trial.
Why Is NeuroBo (NRBO) Stock Up 47% Today?
NeuroBo (NRBO) stock is rising higher on Thursday after the company announced a new strategic partnership with Dong-A ST.
KRYS Stock Alert: The Study Results That Have Krystal Biotech Rocketing 118% Today
Krystal Biotech (KRYS) stock is rising higher on Monday thanks to positive results from a recent Phase 3 clinical trial of VYJUVEK.
KTTA Stock Alert: 6 Things to Know About Pasithea Therapeutics as Shares Soar Today
Pasithea Therapeutics (KTTA) stock is heading higher on heavy trading Thursday even without any recent news from the biotech company.
Why Is Ensyce Biosciences (ENSC) Stock Down 27% Today?
Ensyce Biosciences (ENSC) stock is taking a beating on Friday after the clinical-stage biotech company announced $8 million in financing.
Why Is CASI Pharmaceuticals (CASI) Stock Up 700% Today?
CASI Pharmaceuticals (CASI) stock rocketed higher in pre-market trading this morning but it’s not due to any positive news from the company.
Bluebird (BLUE) Stock Soars 25% Following 2 FDA Recommendations
Bluebird Bio (BLUE) stock is gaining on Monday following positive news last week from an advisory committee set up by the FDA.
Penny Biotech Stocks: 8 Things for Verastem Investors to Know as VSTM Stock Shoots Higher
Verastem (VSTM) stock is on the rise Monday morning following an announcement from the company concerning a deal with Amgen (AMGN).
LIFE Stock: 7 Things to Know About Biotech aTyr Pharma as Shares Soar on Study Results
Atyr Pharma (LIFE) stock is soaring higher on Tuesday after the company released positive data from a recent clinical trial.
SESN Stock: Why Sesen Bio Is Getting Slammed Today
Sesen Bio (SESN) stock is taking a beating on Monday following a letter from the U.S. Food and Drug Administration (FDA).
SNGX Stock: The Big FDA News Giving Biotech Penny Stock Soligenix a Boost
Soligenix (SNGX) stock is roaring higher on Thursday thanks to some positive news from the U.S. Food and Drug Administration today.
AUPH Stock: 13 Things to Know About Aurinia Pharma as Shares Crash Today
Aurinia Pharma (AUPH) stock is taking a beating on Monday following a filing with the SEC after markets closed on Friday.
NCNA Stock: The Big Cancer Drug News Sending NuCana Skyrocketing
NuCana (NCNA) stock is surging higher on Wednesday after the company revealed fast track designation from the FDA for Acelarin.
GHSI Stock: 12 Things to Know About Guardion Health Science as Shares Rocket
Guardion Health Science (GHSI) stock is taking off on Wednesday thanks to a presentation taking place today and heavy trading.
NRBO Stock: 6 Things to Know About NeuroBo Pharma as Retail Investors Send Shares Rocketing
Neurobo Pharmaceuticals (NRBO) stock is on the rise Tuesday as retail traders take a liking to the biotechnology company.
5 – 8 of 176 results
